TAZ Antikörper (AA 46-240)

Produktnummer ABIN7439516

Produktdetails anti-TAZ Antikörper

Target: TAZ (Tafazzin (TAZ))

Bindungsspezifität: AA 46-240

Reaktivität: Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser TAZ Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)

Verwendungszweck: Polyclonal Antibody to Tafazzin (TAZ)

Spezifität: The antibody is a rabbit polyclonal antibody raised against TAZ. It has been selected for its ability to recognize TAZ in immunohistochemical staining and western blotting.

Aufreinigung: Antigen-specific affinity chromatography followed by Protein A affinity chromatography

Immunogen: Recombinant Tafazzin (TAZ) corresdonding to Asn46~Phe240 (Accession # I7HJS2)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

Western blotting: 0.5-2 μg/mL

Immunohistochemistry: 5-20 μg/mL

Immunocytochemistry: 5-20 μg/mL

Optimal working dilutions must be determined by end user.

Kommentare:

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Haltbarkeit: 24 months

Details zu TAZ

Target: TAZ (Tafazzin (TAZ))

Andere Bezeichnung: Tafazzin (TAZ Produkte)

Synonyme: wu:fb39f12 antikoerper, zgc:91803 antikoerper, MGC54019 antikoerper, TAZ antikoerper, taz antikoerper, GB11956 antikoerper, Afu2g13960 antikoerper, BTHS antikoerper, CMD3A antikoerper, EFE antikoerper, EFE2 antikoerper, G4.5 antikoerper, LVNCX antikoerper, Taz1 antikoerper, 5031411C02Rik antikoerper, 9130012G04Rik antikoerper, AW107266 antikoerper, AW552613 antikoerper, tafazzin antikoerper, tafazzin L homeolog antikoerper, tafazzin homolog antikoerper, TAZ antikoerper, taz antikoerper, taz.L antikoerper, LOC550948 antikoerper, AFUA_2G13960 antikoerper, AOR_1_318014 antikoerper, Tsp_06712 antikoerper, Taz antikoerper

Hintergrund: CMD3A, EFE2, EFE, BTHS, XAP-2, G4.5, Barth syndrome, Endocardial Fibroelastosis 2, Cardiomyopathy,Dilated 3A(X-Linked)